Guardant Health
About
Guardant360 is a comprehensive liquid biopsy test that analyzes ctDNA to identify genomic alterations and guide treatment decisions.
Guardant360 Liquid Biopsy
Coverage & Insurance
Accepted
Available
Required
In-network carriers
Cancer types served
Related Providers
Tempus
5 offeringsTempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Foundation Medicine
4 offeringsFoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Invitae
2 offeringsInvitae offers genetic testing for hereditary cancer syndromes including BRCA1/2, Lynch syndrome, and other inherited cancer risks.
Protean 600+
Comprehensive genomic profiling analyzing 600+ cancer-related genes to identify actionable mutations and guide treatment selection.
Get personalized guidance for your case
This is general information. Upload your records for analysis specific to YOUR diagnosis.